• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Where does nation have to be to even qualify for double down Q2?









And in August when you get your final bonus, you will also get a letter saying unfortunately, the Nation fell below the 100.5 threshold.....ie: We needed the money to have a worthless meeting in Dallas to yuk it up and watch zombies roam around in a haze....